Patents by Inventor Haojian ZHANG

Haojian ZHANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Catalytic hydrogenation method for carbon nine resin
    Patent number: 11958930
    Abstract: The present invention discloses a catalytic hydrogenation method for carbon nine resin, comprising the following steps: 1) adding a Pt—W—Y/?-Al2O3 catalyst in the first half of a fixed bed, adding a Pd—Zr—Nd/?-Al2O3 catalyst in the second half of the fixed bed, and feeding hydrogen for reduction; and 2) catalytic hydrogenating the pretreated carbon nine resin in the fixed bed. In the present invention, different catalysts capable of reacting under the same catalytic conditions are added in the first and second halves of the fixed bed, and the two different catalysts play different roles, and can be active and complementary to each other under the same conditions. The synergistic effect of the two catalysts plays a good catalytic role. Moreover, the production process is simplified, and the production cost is saved.
    Type: Grant
    Filed: April 24, 2020
    Date of Patent: April 16, 2024
    Assignee: NINGBO UNIVERSITY OF TECHNOLOGY
    Inventors: Jianghua Fang, Hui Huang, Weihong Xu, Ying Li, Haojian Zhang, Xunwen Xiao, Bin Wang, Minjie Hu
  • COMPOSITIONS AND METHODS OF TREATING FANCONI ANEMIA
    Publication number: 20240000823
    Abstract: The present invention provides methods of treating, preventing or delaying the onset of bone marrow failure in Fanconi Anemia patients
    Type: Application
    Filed: July 20, 2023
    Publication date: January 4, 2024
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: Alan D'Andrea, Kalindi Parmar, Haojian Zhang
  • Compositions and methods of treating Fanconi Anemia
    Patent number: 11707481
    Abstract: The present invention provides methods of treating, preventing or delaying the onset of bone marrow failure in Fanconi Anemia patients.
    Type: Grant
    Filed: February 26, 2016
    Date of Patent: July 25, 2023
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Alan D'Andrea, Kalindi Parmar, Haojian Zhang
  • CATALYTIC HYDROGENATION METHOD FOR CARBON NINE RESIN
    Publication number: 20220325010
    Abstract: The present invention discloses a catalytic hydrogenation method for carbon nine resin, comprising the following steps: 1) adding a Pt—W—Y/?-Al2O3 catalyst in the first half of a fixed bed, adding a Pd—Zr—Nd/?-Al2O3 catalyst in the second half of the fixed bed, and feeding hydrogen for reduction; and 2) catalytic hydrogenating the pretreated carbon nine resin in the fixed bed. In the present invention, different catalysts capable of reacting under the same catalytic conditions are added in the first and second halves of the fixed bed, and the two different catalysts play different roles, and can be active and complementary to each other under the same conditions. The synergistic effect of the two catalysts plays a good catalytic role. Moreover, the production process is simplified, and the production cost is saved.
    Type: Application
    Filed: April 24, 2020
    Publication date: October 13, 2022
    Applicant: NINGBO UNIVERSITY OF TECHNOLOGY
    Inventors: Jianghua FANG, Hui HUANG, Weihong XU, Ying LI, Haojian ZHANG, Xunwen XIAO, Bin WANG, Minjie HU
  • Anti-TGF-beta antibody for the treatment of fanconi anemia
    Patent number: 10526402
    Abstract: The present invention provides methods of treating, preventing or delaying the onset of bone marrow failure in Fanconi Anemia patients comprising administering to the patient a composition comprising a neutralizing anti-TGF-beta antibody, e.g. fresolimumab or 1D11.
    Type: Grant
    Filed: February 25, 2016
    Date of Patent: January 7, 2020
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Alan D'Andrea, Kalindi Parmar, Haojian Zhang
  • COMPOSITIONS AND METHODS OF TREATING FANCONI ANEMIA
    Publication number: 20180071330
    Abstract: The present invention provides methods of treating, preventing or delaying the onset of bone marrow failure in Fanconi Anemia patients.
    Type: Application
    Filed: February 26, 2016
    Publication date: March 15, 2018
    Inventors: Alan D'ANDREA, Kalindi PARMAR, Haojian ZHANG
  • ANTI-TGF-BETA ANTIBODY FOR THE TREATMENT OF FANCONI ANEMIA
    Publication number: 20180051075
    Abstract: The present invention provides methods of treating, preventing or delaying the onset of bone marrow failure in Fanconi Anemia patients comprising administering to the patient a composition comprising a neutralizing anti-TGF-beta antibody, e.g. fresolimumab or 1D11.
    Type: Application
    Filed: February 25, 2016
    Publication date: February 22, 2018
    Inventors: Alan D'ANDREA, Kalindi PARMAR, Haojian ZHANG